37 results on '"Staser, Karl"'
Search Results
2. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
3. A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
4. Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR
5. Immunotherapy for T-Cell ALL and T-Cell NHL
6. Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model
7. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review
8. Research Techniques Made Simple: CAR T-Cell Therapy
9. The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia
10. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
11. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
12. An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
13. Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
14. An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies
15. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
16. Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR
17. Histopathologic and immunophenotypic features of cutaneous solid organ transplant‐associated graft‐vs‐host disease: Comparison with acute hematopoietic cell transplant‐associated graft‐vs‐host disease and cutaneous drug eruption
18. 364 - Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
19. Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
20. Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy
21. A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates CART Proliferation, Differentiation, and Tumor Killing
22. Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy
23. A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates Ucart Proliferation, Differentiation, and Tumor Killing
24. Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair
25. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas
26. Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer
27. OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood
28. An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies
29. Injection-Site Cutaneous Pseudolymphoma Induced by a GM-CSF–Producing Tumor Cell Vaccine
30. Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis
31. proteasome-resistant fragment of NIK mediates oncogenic NF- κ B signaling in schwannomas.
32. OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.
33. Nf1Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis
34. Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation
35. Pleomorphic soft tissue sarcoma metastatic to the skin of the scalp and groin
36. Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.
37. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.